<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00372281</url>
  </required_header>
  <id_info>
    <org_study_id>3780</org_study_id>
    <nct_id>NCT00372281</nct_id>
  </id_info>
  <brief_title>Cliavist in Infectious and Degenerative Diseases of the Spine</brief_title>
  <official_title>Comparison of Cliavist Enhancement in Infectious and Degenerative Diseases of the Spine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      USPIO contrast enhancement results from intracellular trapping of the iron particles in
      reactive cells, especially macrophages. 17FDG-PET studies have demonstrated that macrophages
      are present in spine infectious diseases but are absent in spine degenerative diseases. The
      aim of this work is to compare the enhancement induced by CLIAVIST in both diseases. The
      absence of macrophages in degenerative lesions should help to differentiate them from
      infectious lesions, who should present contrast enhancement in relation to the presence of
      macrophages.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2007</start_date>
  <completion_date type="Anticipated">December 2009</completion_date>
  <primary_completion_date type="Anticipated">August 2009</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First MRI: performed immediately after gadolinium administration</measure>
    <time_frame>immediately after gadolinium administration</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Second MRI: performed 24 hours after cliavist administration</measure>
    <time_frame>24 hours after cliavist administration</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Spine Infection</condition>
  <arm_group>
    <arm_group_label>Cliavist</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cliavist</intervention_name>
    <description>Injection of 0,9 mL (weight &lt; 60kg) or 1,4 mL (weight &gt; 60kg) of Cliavist (ferucarbotran) by direct intraveinous way, 48 h following the MRI done with gadolinium.</description>
    <arm_group_label>Cliavist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  spine infection or spine degenerative disease

          -  patient agreement obtained

        Exclusion Criteria:

          -  pregnancy

          -  MRI contra-indications

          -  cliavist contra-indication

          -  dextran allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Louis Dietemann, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Louis Dietemann, MD</last_name>
    <phone>(33) 3 88127888</phone>
    <email>jean-louis.dietemann@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stéphane Kremer, MD</last_name>
    <phone>(33) 3 88127888</phone>
    <email>stephane.kremer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Neuroradiologie - Hôpital Central</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serge Bracard, MD</last_name>
      <email>s.bracard@chu-nancy.fr</email>
    </contact>
    <contact_backup>
      <last_name>Emmanuelle Schmitt, MD</last_name>
      <email>e.schmitt@chu-nancy.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Serge Bracard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Emmanuelle Schmitt, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nouvel Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guillaume BIERRY, MD</last_name>
      <phone>33 (3) 88116280</phone>
      <email>guillaume.bierry@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Guillaume BIERRY, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Radiologie 2 - Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-louis Dietemann, MD</last_name>
      <email>jean-louis.dietemann@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Stephane Kremer, MD</last_name>
      <email>stephane.kremer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Jean-Louis Dietemann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane Kremer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Rhumatologie - Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean Sibilia, MD</last_name>
      <email>jean.sibilia@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Jean Sibilia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 4, 2006</study_first_submitted>
  <study_first_submitted_qc>September 4, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 6, 2006</study_first_posted>
  <last_update_submitted>February 24, 2009</last_update_submitted>
  <last_update_submitted_qc>February 24, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Christine GEILLER</name_title>
    <organization>Direction de la Recherche Clinique et de l'Innovation - Hôpitaux Universitaires de Strasbourg</organization>
  </responsible_party>
  <keyword>MRI, CLIAVIST, MACROPHAGE, INFECTION, SPINE</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

